Up and Down: United Therapeutics, NCI, Deltek, Vanda

In a short trading week, the S&P 500 took its fifth straight weekly fall, dropping 1.3 percent. The Post/Bloomberg index fell 3.6 percent.

*United Therapeutics (UTHR) was the biggest gainer last week, with shares of the Silver Spring biotech gaining 9 percent, to $102.70. Shares went as high as $106.24 on Thursday, their 52-week high. On Monday, the company applied for approval of an inhaled form of its pulmonary arterial hypertension drug. Shares are 60 percent higher than they were a year ago.

*Shares of NCI (NCIT) of Reston also hit a 52-week high on Thursday, climbing to $24.95 before falling a few cents to close at $24.91. Shares of the IT company are up 31 percent in the past three months and 50 percent in the past year. They were added to the Russell 3000 index last week. NCI reported in April that first-quarter profit rose almost 26 percent and is scheduled to report second-quarter results July 29.

*And another 52-week high: Hanger Orthopedic Group (HGR), a Bethesda-based provider of prosthetics and orthotics. Shares closed at $15.86, up 5 percent for the week, after hitting the year high of $16.63 on Monday. They've gained 42 percent in the past three months. On Wednesday, S&P revised its outlook for Hanger to "positive" from "stable" and confirmed its credit rating of "B," citing "positive prospects for WalkAide and our expectation for an improved financial risk profile."

*Carrollton Bancorp (CRRB) of Baltimore fell 27 percent last week, closing Thursday at $8.95. They closed at their 52-week low of $8.75 Wednesday. In mid-May, the bank said it increased its provision for loan losses to $99,000 from $66,000; shares were trading then around $13.

*Shares of Deltek (PROJ) are down 49 percent in the past three months and fell 23 percent last week, closing Thursday at $6.50. They hit their 52-week low of $6.49 on Wednesday, the same day the Herndon software firm was downgraded from "overweight" to "neutral" by J.P. Morgan.

*Freddie Mac (FRE) shares have now lost 76 percent of their value in the past 52 weeks. They're down 48 percent in the past three months and fell 22 percent last week, closing Thursday at $14.50. Fannie Mae (FNM) shares fell 10 percent last week, not enough to make our list of top 10 losers for the week. But they're down 38 percent in the past three months and 71 percent in the past year.

*Vanda Pharmaceuticals (VNDA) now has the top spot on our list of 52-week losers. Shares fell 21 percent last week and are down 83 percent in the past year, closing Thursday at $3.31. The most recently fall came after the Rockville firm's June 26th announcement that an insomnia drug missed some goals.

By Terri Rupar  |  July 7, 2008; 12:17 PM ET  | Category:  Wall Street
Previous: Early Briefing: Jared Lost With Subway. Larry Feldman Won. | Next: ExecuTube: The Subway King of the Mid-Atlantic


Please email us to report offensive comments.

The comments to this entry are closed.

RSS Feed
Subscribe to The Post

© 2010 The Washington Post Company